ID
23551
Description
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00576901
Link
https://clinicaltrials.gov/show/NCT00576901
Keywords
Versions (1)
- 7/8/17 7/8/17 -
Uploaded on
July 8, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00576901
Eligibility Breast Cancer NCT00576901
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Neoplasm Metastasis TNM clinical staging
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C3258246
Description
Prior Therapy Breast Carcinoma
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0678222
Description
CNS metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
Description
Aspirin U/day | Avastin | Anti-Inflammatory Agents, Non-Steroidal | Anticoagulants Dose Full
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004057
- UMLS CUI [1,2]
- C0456683
- UMLS CUI [2]
- C1135130
- UMLS CUI [3]
- C0003211
- UMLS CUI [4,1]
- C0003280
- UMLS CUI [4,2]
- C0178602
- UMLS CUI [4,3]
- C0443225
Description
Cardiovascular Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007222
Similar models
Eligibility Breast Cancer NCT00576901
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0333348 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0474926 (UMLS CUI [1,4])
C3258246 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003211 (UMLS CUI [3])
C0003280 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0443225 (UMLS CUI [4,3])